Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Feb 28;39(2):169-174.
doi: 10.12122/j.issn.1673-4254.2019.02.07.

[Effect of methanol-ethyl acetate partitioned fractions from Descurainia sophia on proliferation and apoptosis of human non-small cell lung cancer H1975 cells]

[Article in Chinese]
Affiliations

[Effect of methanol-ethyl acetate partitioned fractions from Descurainia sophia on proliferation and apoptosis of human non-small cell lung cancer H1975 cells]

[Article in Chinese]
Jiahui Gui et al. Nan Fang Yi Ke Da Xue Xue Bao. .

Abstract

Objective: To investigate the effects of methanol-ethyl acetate partitioned fractions from Descurainia sophia (MEDS) on the proliferation and apoptosis of human non-small cell lung cancer H1975 cells.

Methods: The systemic solvent extraction method was used to preliminary separation of the effective fractions in the methanol extract of Descurainia sophia. The cytotoxicity of each extract (5, 10, 20, 40, and 80 μg/mL) was tested using MTT assay. Colony cloning method was used to assess the effect of different concentrations of methanol-ethyl acetate partitioned fractions from MEDS (5, 10, 20, 40, and 80 μg/ mL) on the proliferation of H1975 cells. Flow cytometric analysis with Annexin V-FITC/PI staining was performed to detect the apoptosis of the cells after treatment with different concentrations of MEDS fractions (10, 20, and 40 μg/mL). Western blotting was used to evaluate the effects of MEDS fractions on the expressions of apoptosis-related proteins Akt, Bax, and Bcl-2. The anti-tumor activity of 100 mg/kg MEDS fractions was tested in a nude mouse model bearing H1975 cell xenografts.

Results: MTT assay and colony forming experiment showed that MEDS fractions significantly inhibited the proliferation of H1975 cells in a dose-and time-dependent manner (P < 0.05). The results of flow cytometry showed that MEDS fractions induced obvious apoptosis of H1975 cells in a concentration-dependent manner (P < 0.05). MEDS fractions also significantly decreased the expressions of Bcl-2 and Akt protein and increased the protein expression of Bax (P < 0.05). In the tumor-bearing nude mouse model, MEDS fractions showed potent anti-tumor effects with a low toxicity to affect the body weight and organs of the mice.

Conclusions: The methanol-ethyl acetate partitioned fractions from MEDS show potent anti-tumor activity both in vivo and in vitro, suggesting their value as promising therapeutic agents against lung cancer.

目的: 探讨南葶苈子的乙酸乙酯浸膏对人非小细胞肺癌H1975细胞增殖、凋亡的影响。

方法: 采用系统溶剂萃取法对南葶苈子甲醇浸膏进行初步分离。MTT法检测各萃取浸膏(5、10、20、40、80 μg/mL)的细胞毒性。集落克隆法检测不同浓度的南葶苈子乙酸乙酯浸膏(0.625、1.25、2.5 μg/mL)对人非小细胞肺癌H1975细胞增殖的影响。Annexin V-FITC/PI双染及流式细胞术检测不同浓度的乙酸乙酯浸膏(0、10、20、40 μg/mL)对人非小细胞肺癌H1975细胞凋亡的影响。免疫印迹法检测不同浓度乙酸乙酯浸膏(0、10、20、40 μg/mL)对凋亡相关蛋白Akt、Bax及Bcl-2蛋白表达的影响。建立人非小细胞肺癌H1975细胞裸鼠移植瘤模型, 设置空白组, 给药组(100 mg/kg), 阳性对照组, 观察乙酸乙酯浸膏的体内抗肿瘤活性。

结果: MTT和集落克隆结果显示, 乙酸乙酯浸膏呈剂量依赖、时间依赖方式抑制人非小细胞肺癌H1975细胞增殖。与对照组相比, 差异均具有统计学意义(P < 0.05)。流式细胞术结果表明, 乙酸乙酯浸膏能显著诱导人非小细胞肺癌H1975细胞发生凋亡(P < 0.05), 并且呈现浓度依赖性。Western blot结果显示, 乙酸乙酯浸膏可降低蛋白Bcl-2、Akt的表达, 增加蛋白Bax的表达(P < 0.05)。另外, 南葶苈子乙酸乙酯浸膏表现出较好的体内抗肿瘤活性, 对裸鼠体质量和器官的毒性较小。

结论: 南葶苈子的乙酸乙酯浸膏具有较强的体内、体外抗肿瘤作用, 具有成为抗肺癌药物的潜力。

Keywords: Descurainia sophia; apoptosis; cytotoxicity; human non-small cell lung cancer.

PubMed Disclaimer

Figures

1
1
MEDS对人肺癌H1975细胞增殖的影响 Anti-proliferation effects of MEDS in human non-small cell lung cancer H1975 cell line. A:Dose-and time-response curve of the effect of MEDS on cell viability in H1975 cells; B: Representative images of H1975 cell colonies treated with MEDS for 7 days; C:Quantitifaction of the clone counts demonstrated that treatment with MEDS had a significantly inhibitory effect on colony formation in the H1975 cells. *P < 0.05 vs control group.
2
2
MEDS的体内抗肿瘤活性 Anti-tumor effects of MEDS on H1975 cell tumor xenograft growth in nude mice. A:Representative images of tumors from control group, MEDS, and 17-DMAG; B:Tumor volume of the mice; C:Body weight of the mice; D:The GOT and GPT activities (U/L); E:HE staining of the tumor, lung, liver, and kidney tissues form the mice (Original magnification:× 200). *P < 0.05 vs control groups.
3
3
南葶苈子乙酸乙酯浸膏对H1975细胞凋亡的影响 MDES induces apoptosis in the human lung cancer H1975 cell line. A:Cell apoptosis measured by the Annexin VFITC/PI analysis using flow cytometry; B:Expression of Akt, Bcl-2, and Bax proteins detected by Western blotting; C: Quantitative analysis of Bax/Bcl-2 ratio in H1975 cells relative to that in the control cells. *P < 0.05 vs control group.

Similar articles

Cited by

References

    1. Wakelee H, Kelly K, Edelman MJ. 50 Years of progress in the systemic therapy of non-small cell lung cancer[M]. Am Soc Clin Oncol Educ Book, 2014: 177-89.

    1. Molina JR, Yang P, Cassivi SD, et al. Non-small cell lung cancer:epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 2008;83(5):584–94. doi: 10.1016/S0025-6196(11)60735-0. [Molina JR, Yang P, Cassivi SD, et al. Non-small cell lung cancer:epidemiology, risk factors, treatment, and survivorship[J]. Mayo Clin Proc, 2008, 83(5):584-94.] - DOI - PMC - PubMed
    1. Wang LJ, Yu CH, Liu Y, et al. Lung cancer mortality trends in China from 1988 to 2013:new challenges and opportunities for the government. Int J Environ Res Public Health. 2016;13(11):1052. doi: 10.3390/ijerph13111052. [Wang LJ, Yu CH, Liu Y, et al. Lung cancer mortality trends in China from 1988 to 2013:new challenges and opportunities for the government[J]. Int J Environ Res Public Health, 2016, 13(11):1052.] - DOI - PMC - PubMed
    1. Reck M, Heigener DF, Mok T, et al. Management of non-small-cell lung cancer:recent developments. Lancet. 2013;382(9893):709–19. doi: 10.1016/S0140-6736(13)61502-0. [Reck M, Heigener DF, Mok T, et al. Management of non-small-cell lung cancer:recent developments[J]. Lancet, 2013, 382(9893):709-19.] - DOI - PubMed
    1. Tan DS, Camilleri-Broët S, Tan EH, et al. Intertumor heterogeneity of non-small-cell lung carcinomas revealed by multiplexed mutation profiling and integrative genomics. Int J Cancer. 2014;135(5):1092–100. doi: 10.1002/ijc.v135.5. [Tan DS, Camilleri-Broët S, Tan EH, et al. Intertumor heterogeneity of non-small-cell lung carcinomas revealed by multiplexed mutation profiling and integrative genomics[J]. Int J Cancer, 2014, 135(5):1092-100.] - DOI - PubMed